Access cutting-edge psoriasis treatment through this clinical trial at a research site in New York. Study-provided care at no cost to qualified participants.
Access psoriasis specialists in New York at no cost
This study follows strict safety protocols and ethical guidelines
All study-related psoriasis treatment provided free
This is a multi-center (North-America), randomized, double-blind, placebo-controlled, wait-list, interventional, preventive trial of guselkumab in high-risk psoriasis patients compared to non-biologic standard of care. The primary objective of the proposed trial will be to test the hypothesis that a prolonged, unresolved skin inflammation coupled with musculoskeletal power-doppler ultrasound (MSKPDUS) abnormalities driven by IL-23 increase the risk for transition into PsA and that an interventi
Sponsor: NYU Langone Health
Check if you qualify for this psoriasis clinical trial in New York, NY
If you're searching for psoriasis treatment options in New York, NY, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our New York research site is actively enrolling participants for this clinical trial. You'll receive care from experienced psoriasis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.